You Searched For "Sanofi" and got 20 results
Sort By:
Connecting with marketing peers helps CMOs stay on top of trends, says Claudine Patel, CMO of Sanofi Consumer Healthcare
Marketing is dynamic and constantly changing, so networking with a CMO peer group is key to keeping…
2 mins read
Sanofi board approves demerger of its consumer healthcare business
Drug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer health…
PTI
1 min read
Time to bet on dividend income: Top stocks that delivered the highest yield over one year
From the Anil Agarwal-led Vedanta to Hindustan Zinc and Sanofi, here are the companies in the Nifty…
3 mins read
Pfizer agrees to buy Seagen for $43 billion
The agreement is an early sign that, despite the threat of close antitrust examinations and higher …
ANI
1 min read
Sanofi, GSK to seek authorisation for COVID-19 vaccine
Late-stage trials found that two doses of the vaccine were about 58% effective in preventing infect…
1 min read
Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion
The deal represents a 56% premium to Translate Bio's volume-weighted average price per share over t…
Matthew Fox
2 mins read
India's drug controller grants approval to Sanofi and Glaxo Smith Kline to conduct Phase-3 trials of their COVID-19 vaccine
The global, randomised, double-blind Phase-III study will include more than 35,000 volunteers ag…
2 mins read
These are the fastest-growing biotech companies
These are Insider's biggest healthcare stories for May 18.
Lydia Ramsey Pflanzer
1 min read
Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot
The two vaccine-making giants plan to launch a 35,000-person study in the next few weeks, aiming to…
Andrew Dunn
7 mins read
There are one of only 17 Indian companies out of 500 that aced the Du Pont test
Du Pont Corporation in America used a method to calculate the return on equity— which shows how pr…
3 mins read
GSK and Sanofi delay the expected rollout of their COVID-19 vaccine until late 2021 because of an insufficient response in older people. The US has ordered 100 million doses.
The pharmaceutical giants GlaxoSmithKline and Sanofi said they'd improve their formulation and star…
Grace Dean
2 mins read
French drugmaker Sanofi has just invested $59 million in biotech investor Jeito Capital to fund innovation in the biopharma pipeline
Sanofi, one of the world's biggest pharmaceutical companies, has invested €50 million in new French…
Theo Golden,Dr. Catherine Sch…
6 mins read
Pfizer's coronavirus vaccine relies on a new, unproven technology. A diagram shows how it differs from other candidates.
Pfizer announced Monday that its mRNA vaccine, which relies on a snippet of the virus' genome, succ…
Aria Bendix
1 min read
Sanofi, GSK start human trial of their Covid-19 vaccine
Paris, Sep 3 (IANS) Pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) on Thursday started a …
3 mins read
Trump expects a COVID-19 vaccine to arrive this fall, according to a new report — an optimistic timeline that many doubt will come true
Vaccine manufacturers have been working with unusual speed, but many experts predict a much-longer …
Sinéad Baker
1 min read
Drugmakers Sanofi and GSK launch human trials for COVID-19 vaccine
The major European drug companies have begun testing their coronavirus vaccine on humans in the US …
Kate Duffy
2 mins read
Sanofi, GSK to support COVAX with 200mn doses of Covid-19 vaccine
London/Paris, Oct 28 (IANS) Drugmakers Sanofi and GlaxoSmithKline on Wednesday said they plan to ma…
3 mins read
Sanofi walked back a promise to give the US priority access to its coronavirus vaccine after outrage from the French government
CEO Paul Hudson previously said the US "has the right" to its potential vaccine because it had cont…
Bill Bostock
2 mins read
The US would be the first to get a potential coronavirus vaccine being created by a French company, its CEO said
The CEO of Sanofi told Bloomberg the United States would be first because it was the earliest to fu…
Bryan Pietsch
8 mins read
Even if a successful coronavirus vaccine is developed, billions could struggle to access it because of a global shortage of glass vials
Vaccines are stored in glass vials, which are running low, slow to produce, and invariably the main…